The present invention relates to a method of a method of measuring a human body analyte concentration in an interstitial fluid, comprising the step of measuring a first electrical current I.sub.1 between a working electrode and a pseudo-reference electrode while applying a first potential between the working electrode and the pseudo-reference electrode, the first potential being less than a threshold potential, the magnitude of the first electrical current being greater than the magnitude of a predetermined first threshold current, and further measuring an output electrical current between the working electrode and the pseudo-reference electrode while applying a second electrical potential, the second electrical potential being greater than the first electrical potential.

An external end device has a casing (4), a fitting (15) housed in the casing (4) and having at least one distal part (16) which engages a catheter (3), and two proximal tracts (17, 17), in which a pair of curved pipes (18, 18) are inserted with a distal end (180) thereof. The curved pipes (18, 18) have a proximal end (181), in which a pair of nozzles (190, 190) are inserted. Inside each nozzle (190) there is a cap (20) suitable for hermetically sealing the nozzle (190). A piercing and connecting conduit (24) is adapted to reversibly pierce the cap (20) and to connect the pair of nozzles (190, 190) to the flow lines of the treatment equipment. Also disclosed is a method of connecting the external terminal device to flow lines of a machine.

The present invention relates to a non-invasive blood glucose measuring apparatus, for measuring the glucose level in an object of measurement, comprising: (a) an irradiation source, for irradiating a narrow-band wavelength light into said object of measurement containing a blood vessel; (b) an optical detector, for collecting and processing some of the light, irradiated by said irradiating source, which is back-scattered from the object of measurement, (c) sampling means, for sampling said orthogonally polarized beams, provided by said detector-amplifiers, for converting the data of said orthogonally polarized beams into digital codes; and (d) a computing unit, wherein said computing unit comprises an adaptive filter for enhancing the cardiac pulse pulsatile waveform, and wherein said computing unit computes the glucose level, in said object of measurement, by averaging of said sampled codes.

The present disclosure relates to a method for calculating the calibration sensitivity of a sensor for insertion into the body and, more particularly, to a method for calculating calibration sensitivity, wherein a biometric value of a user can be accurately calibrated by overcoming an error in a biometric value measured through a sensor for insertion into the body, or an error in a reference biometric value measured through a biometric information measurement device, by storing past sensitivities and using at least one of the past sensitivities and a currently calculated sensitivity to calculate a calibration sensitivity of the sensor for insertion into the body, and the calibration sensitivity of the sensor for insertion into the body can be accurately calculated, even if there is an error in the reference biometric value or the reference biometric value temporarily deviates from the range of normal biometric values of the user, by determining whether the reference biometric value used to calculate the calibration sensitivity is within an allowable range.

A system and method for positioning a sensor on a subject. In some embodiments, the system includes an instrument holder, the instrument holder being configured to be secured to a subject, and to hold an instrument temporarily.

One or more insertion mechanisms may be configured to insert and retract one or more needles associated with a component configured to implantable component into the tissue of a patient. For example, a component or implantable component may include a cannula for delivery of medication to a patient or an analyte sensor. An insertion mechanism may be configured to be part of or enclosed within a structure of the Disease Management System. For example, an insertion mechanism may be configured to operate within the structure of the Disease Management System and not require outside components or devices to apply one or more needles or implantable components to the patient.

Systems, methods, and computer-readable media for providing a decision support solution to medical professionals to optimize medical care through data monitoring and feedback treatment are provided herein. In another embodiment, a computer-implemented method for modeling patient outcomes resulting from treatment in a specific medical area includes receiving patient-specific data associated with a patient, determining a plurality of possible patient states under which the patient can be categorized, a current patient state under which the patient can be categorized and determining probabilities of the patient transitioning from any of the possible patient states to every other possible patient state.

Systems and methods are disclosed for non-invasively measuring blood glucose levels in a biological sample based on spectral data. This includes utilizing at least one light source configured to strike a target area of a sample, utilizing at least one light filter positioned to receive light transmitted through the target area of the sample from the at least one light source, utilizing at least one light detector positioned to receive light from the at least one light source and filtered by the at least one light filter, and to generate an output signal, having a time dependent current, which is indicative of the power of light detected, receiving the output signal from the at least one light detector with a processor, calculating the attenuance attributable to blood with a ratio factor based on the received output signal, and determining a blood glucose level based on the calculated attenuance.

An electrode measuring the presence of an analyte is described as one embodiment. The electrode includes a working conductor with an electrode reactive surface and a first reactive chemistry that is responsive to the analyte. The electrode further includes a first transport material that enables flux of the first analyte to the first reactive chemistry and a second transport material that supplies a reactant to the first reactive chemistry. Wherein the first reactive chemistry does not contact the electrode reactive surface while at least partially shadowing a portion of the electrode reactive surface.

An arrangement for operating a biosensor emitting radiation includes an excitation light source, which generates at least one excitation radiation for the biosensor; a coupling fiber, at the entry surface of which the excitation radiation is coupled in; an optical Y-coupler, including an excitation arm, which is connected to the exit surface of the coupling fiber, a detector arm, which is connected to an optical detector, and a sensor foot, which can be connected to the biosensor. The excitation arm has a conical shape. The radiation axis of the excitation arm includes an angle in the range of 5° to 70° with the main radiation axis of the detector arm. The diameter of the excitation arm at the connecting point to the detector arm is less than two thirds the diameter of the detector arm. An arrangement for determining the glucose content blood is also provided.